GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sutro Biopharma Inc (FRA:S09) » Definitions » Other Long-Term Liabilities

Sutro Biopharma (FRA:S09) Other Long-Term Liabilities : €1.6 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Sutro Biopharma Other Long-Term Liabilities?

Sutro Biopharma's other long-term liabilities for the quarter that ended in Jun. 2024 was €1.6 Mil.

Sutro Biopharma's quarterly other long-term liabilities increased from Dec. 2023 (€1.6 Mil) to Mar. 2024 (€1.6 Mil) and increased from Mar. 2024 (€1.6 Mil) to Jun. 2024 (€1.6 Mil).

Sutro Biopharma's annual other long-term liabilities declined from Dec. 2021 (€0.1 Mil) to Dec. 2022 (€0.1 Mil) but then increased from Dec. 2022 (€0.1 Mil) to Dec. 2023 (€1.6 Mil).

Sutro Biopharma Other Long-Term Liabilities Historical Data

The historical data trend for Sutro Biopharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sutro Biopharma Other Long-Term Liabilities Chart

Sutro Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial - - - - -

Sutro Biopharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sutro Biopharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Sutro Biopharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sutro Biopharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sutro Biopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sutro Biopharma Inc (FRA:S09) » Definitions » Other Long-Term Liabilities
Comparable Companies
ZVRA VSTM APLT STOK GLUE ALLK AKBA LYRA ATNM CYDY OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
STRO:USA S09:Germany
Address
111 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Website
https://www.sutrobio.com
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Sutro Biopharma Headlines

No Headlines